The OAI classification implies that the US FDA may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved
Collaboration supports multiple discovery efforts, including vaccines
QIAstat-Dx Viral Vesicular Panel tests for six pathogens that produce similar symptoms
Collaboration focuses on developing and implementing real-world research to drive patient access to cancer medicines
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
Man lost 54 Kgs in 6 months with MGB procedure
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Company creates Younger T Cells for fighting cancer using its NR2F6 technology
New deal strengthens Congenica’s presence in India
Subscribe To Our Newsletter & Stay Updated
